Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
João Paulo Lima Daher(Universidade Federal Fluminense), Andrew B. West(Duke Medical Center)
Cited by 207
Related Papers
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
|Journal of Neuroscience|2012|473
Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation
|Science Advances|2023|217
Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S <i>LRRK2</i> carriers
|Neurology|2016|138
Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
|Molecular Neurodegeneration|2009|94
Gut mucosal cells transfer α-synuclein to the vagus nerve
|JCI Insight|2023|51